UniQuest is the commercialisation company of The University of Queensland (UQ). Established in 1984, it partners with UQ researchers to create impact through the commercialisation of UQ intellectual property (IP). With a track record of forming over 100 start-up companies, UniQuest has been instrumental in the development of notable successes such as the cervical cancer vaccine Gardasil®.
UniQuest's notable achievements include the creation of Spinifex Pharmaceuticals Inc and Inflazome Ltd, which were acquired in two of the largest university start-up exits in Australian history. This commercialisation company has positioned UQ as the leader of research commercialisation in Australasia.
UniQuest operates from Brisbane, Queensland, Australia, and employs 139 individuals. As a privately held company, it continues to drive innovation and impact through its strategic partnerships with UQ researchers.
| Ownership Private Company |
| Parent Company The University of Queensland |
B2B professionals would contact UniQuest for its proven track record in commercialising university research, access to cutting-edge intellectual property, and potential for high-impact partnerships. UniQuest offers a unique opportunity to collaborate with a leader in research commercialisation.
Sales teams selling research commercialisation services, recruiters seeking roles in innovation and entrepreneurship, and partners offering technology transfer and start-up support should reach out to UniQuest.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with UniQuest